Hvivo (HVO)

Sector:

Health Care

Index:

FTSE AIM All-Share

27.40p
   
  • Change Today:
    -0.30p
  • 52 Week High: 30.50
  • 52 Week Low: 14.25
  • Currency: UK Pounds
  • Shares Issued: 680.37m
  • Volume: 2,275,359
  • Market Cap: £186.42m

Venn Life Sciences revenues edge higher

By Josh White

Date: Thursday 20 Jul 2017

LONDON (ShareCast) - (ShareCast News) - Contract research organisation Venn Life Sciences said its new financial year "started well" in a trading update on Thursday, with contract wins of €5.7m secured in January and February.
The AIM-traded firm said that overall, it achieved total revenues of €9.1m for the six months to 30 June, up from €8.84m in the first half of last year.

"Our client and revenue mix remains well balanced with strong rates of repeat business and we have successfully delivered initial cross sales between the early and late phase client bases," Venn's board said in its statement.

"We have a strong proposals book which coupled with this solid first half performance provides confidence around full year revenue expectations."

Venn Life Sciences finished the first half year with a cash position of €2.9m - up from €1.75m on 30 June 2016.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Hvivo Market Data

Currency UK Pounds
Share Price 27.40p
Change Today -0.30p
% Change -1.08 %
52 Week High 30.50
52 Week Low 14.25
Volume 2,275,359
Shares Issued 680.37m
Market Cap £186.42m

Hvivo Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
95.39% below the market average95.39% below the market average95.39% below the market average95.39% below the market average95.39% below the market average
81.82% below the sector average81.82% below the sector average81.82% below the sector average81.82% below the sector average81.82% below the sector average
Price Trend
92.92% above the market average92.92% above the market average92.92% above the market average92.92% above the market average92.92% above the market average
94.44% above the sector average94.44% above the sector average94.44% above the sector average94.44% above the sector average94.44% above the sector average
Income
94.2% below the market average94.2% below the market average94.2% below the market average94.2% below the market average94.2% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
43.29% above the market average43.29% above the market average43.29% above the market average43.29% above the market average43.29% above the market average
72.22% above the sector average72.22% above the sector average72.22% above the sector average72.22% above the sector average72.22% above the sector average

What The Brokers Say

Strong Buy 3
Buy 3
Neutral 0
Sell 0
Strong Sell 0
Total 6
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Hvivo Dividends

  Latest Previous
  Final Special
Ex-Div 18-Apr-24 04-May-23
Paid 20-May-24 09-Jun-23
Amount 0.20p 0.45p

Trades for 14-Jun-2024

Time Volume / Share Price
09:15 500,000 @ 27.75p
13:16 500,000 @ 27.50p
16:37 2,143 @ 27.40p
16:37 2,143 @ 27.40p
16:09 18,138 @ 27.50p

Hvivo Key Personnel

CEO Yamin Mo' Khan

Top of Page